Firms
Theme

BAH

Booz Allen Hamilton Holding Corporation · NYSE

News

15 latest

Zacks Investment Research

Booz Allen (BAH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Booz Allen Hamilton reported Q2 revenue of $2.78 billion, down 3.9% year-over-year and slightly missing the $2.8 billion consensus estimate. However, EPS of $1.76 significantly beat expectations of $1.44, representing a +22.22% surprise.

Zacks Investment Research

Booz Allen Hamilton (BAH) Q2 Earnings Beat Estimates

Booz Allen Hamilton reported Q3 2026 earnings of $1.76 per share, beating consensus estimates of $1.44 by 22.22%, though revenues of $2.78 billion missed expectations by 0.81%. The stock has underperformed the S&P 500 by 6.9% year-to-date but holds a Zacks Rank #2 (Buy) rating based on favorable estimate revisions. CRA International is expected to report results on November 5 with projected earnings of $2.06 per share and revenues of $198.64 million.

Zacks Investment Research

Technology Investments & Improved Execution Aid BAH Amid Rising Costs

Booz Allen Hamilton reported Q1 fiscal 2027 earnings that rose 22.3% to $1.81 per share, beating consensus estimates, despite a 4.2% revenue decline to $2.80 billion. The company benefited from sustained National Security demand, improved margins (up 130 basis points to 11.9%), and strong free cash flow growth of 171.9%. However, the company faces headwinds from federal procurement delays, a significant 16.4% decline in Civil segment revenues, and leverage uncertainty from recent acquisitions totaling $955 million.

Zacks Investment Research

Booz Allen Hamilton (BAH) Expected to Beat Earnings Estimates: Should You Buy?

Booz Allen Hamilton is expected to report Q3 2026 earnings of $1.44 per share (down 3.4% YoY) and revenues of $2.8 billion (down 3.1% YoY) on October 23. Despite declining earnings and revenues, the company has a positive Earnings ESP of +5.31% combined with a Zacks Rank #2 (Buy), suggesting a likely earnings beat. The company has beaten consensus estimates in 3 of the last 4 quarters, with a notable +21.48% surprise in the most recent quarter.

Zacks Investment Research

These 2 Business Services Stocks Could Beat Earnings: Why They Should Be on Your Radar

The article highlights two business services stocks with positive Earnings Surprise Prediction (ESP) figures that could beat analyst expectations in their upcoming earnings reports. Visa (V) has an ESP of +0.86% with earnings on October 27, 2026, while Booz Allen Hamilton (BAH) has an ESP of +5.31% with earnings on October 23, 2026. Both stocks are identified as having strong potential for positive earnings surprises based on recent analyst revisions.

Zacks Investment Research

Why Investors Need to Take Advantage of These 2 Business Services Stocks Now

The article explains how investors can use the Zacks Earnings ESP (Expected Surprise Prediction) filter to identify stocks likely to beat earnings expectations. It highlights two Business Services stocks with positive ESPs: Booz Allen Hamilton (BAH) with a +5.31% ESP and Visa (V) with a +0.86% ESP, both scheduled to report earnings in late October 2026. The strategy combines positive ESP with Zacks Rank #3 or better, which historically produced 70% positive earnings surprises and ~28% average annual returns.

Zacks Investment Research

Booz Allen Hamilton (BAH) Surpasses Market Returns: Some Facts Worth Knowing

Booz Allen Hamilton (BAH) outperformed the S&P 500 with a +1.47% daily gain on October 9, 2026. However, the company faces headwinds with forecasted EPS declining 3.36% YoY and revenue down 3.09% for the upcoming quarter. The stock holds a Zacks Rank #3 (Hold) rating and trades at a Forward P/E of 11.67, below its industry average of 15.21, suggesting a valuation discount.

Zacks Investment Research

Booz Allen Hamilton (BAH) Stock Sinks As Market Gains: Here's Why

Booz Allen Hamilton (BAH) fell 4.43% in recent trading, underperforming the broader market. The defense contractor faces headwinds with expected Q3 2026 earnings declining 3.36% year-over-year to $1.44 per share, though annual revenue is projected to grow 2.08%. The stock holds a Zacks Rank #3 (Hold) rating with a Forward P/E of 11.28, trading at a discount to its industry average.

Zacks Investment Research

Why Booz Allen (BAH) is Poised to Beat Earnings Estimates Again

Booz Allen Hamilton (BAH), a defense contractor in the consulting services industry, is highlighted as a stock likely to beat upcoming earnings estimates. The company has demonstrated a strong earnings-beat streak with an average surprise of 28.16% over the last two quarters. With a positive Earnings ESP of +5.31% and a Zacks Rank #3 (Hold), the combination suggests a high probability of another earnings beat in the next report expected on October 23, 2026.

Zacks Investment Research

Booz Allen Hamilton (BAH) Surpasses Market Returns: Some Facts Worth Knowing

Booz Allen Hamilton ended trading at $70.47, up 1.51% and outperforming the S&P 500's 0.2% gain. However, the stock has declined 5.13% over the past month.

Mentions BAH

GlobeNewswire Inc.

Onward FX Names 173 Startups That Made the Cut for Its Fall Program

The Onward FX program has selected 173 startups from nearly 800 applicants for its first cycle focused on the physical economy. The event on October 27 in Little Rock will feature curated meetings between founders and 44 investors including Eclipse, In-Q-Tel, Chevron Technology Ventures, and others. Historically, one in four participating startups secures a term sheet, with investor interest concentrated on industrial AI, critical materials processing, and dual-use hardware.

Zacks Investment Research

Equifax Gears Up to Post Q3 Earnings: What Should Investors Know?

Equifax is expected to report Q3 2026 results on October 20 with revenues projected to rise 9.6% year-over-year to $1.7B and EPS growth of 7.8% to $2.20. The company's Workforce Solutions segment is anticipated to grow 12%, while USIS and International segments are expected to show solid margin expansion. However, the Zacks model does not predict an earnings beat due to a negative Earnings ESP of -0.59% and a Zacks Rank of 4 (Sell).

Zacks Investment Research

Healthcare Services Group Gears Up for Q3 Earnings: What's in Store?

Healthcare Services Group (HCSG) is set to report Q3 2026 results on October 21 with projected revenues of $475-$485M. The company faces headwinds from timing of new business starts, food and labor inflation, lower insurance reserve benefits, and customer payment delays. While HCSG has a strong earnings surprise history, the Zacks model does not predict a beat this quarter with an Earnings ESP of 0.00% and Rank #3 (Hold).

GlobeNewswire Inc.

Global Cyber Warfare Market Size and Forecast to 2031 | AI-Driven Defense, Space Security, and Cloud Adoption Fuel 14.1% CAGR and a USD 28.75 Billion Opportunity

The global cyber warfare market is projected to grow from USD 14.99 billion in 2026 to USD 28.75 billion by 2031, with a CAGR of 14.1%. Growth is driven by increasing cyber threats to military networks, AI-driven defense solutions, space-based security demands, and defensive cyber operations. The Middle East is positioned for the second-highest regional growth rate.

The Motley Fool

Palantir Looks Like a Consulting Company. Its Numbers Tell a Different Story.

Despite criticism that Palantir operates like a consulting firm, its financial metrics reveal a highly scalable software business. With 93% YoY revenue growth, 62% operating margins, and $1.2B in adjusted free cash flow, Palantir demonstrates economics typical of software companies rather than labor-intensive consulting.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $BAH · 0 threads

Sign in to post on $BAH

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev